S. 2042 · 115th Congress
Reducing Drug Waste Act of 2017
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
4 cosponsors · 3 D, 1 R
3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill requires the Food and Drug Administration and the Centers for Medicare & Medicaid Services to develop a joint action plan to reduce drug waste and better manage costs with respect to drug vial sizes and other drug delivery systems.
What it does: CRS summary · Introduced in Senate · Oct 31, 2017
Reducing Drug Waste Act of 2017
This bill requires the Food and Drug Administration and the Centers for Medicare & Medicaid Services to develop a joint action plan to reduce drug waste and better manage costs with respect to drug vial sizes and other drug delivery systems.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Reducing Drug Waste Act of 2017
Latest action (Oct 31, 2017): Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: Senate · Introduced: Oct 31, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.